Byrne Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,802
| Closed | -$264K | – | 96 |
|
|
2025
Q1 | $264K | Sell |
3,802
-365
| -9% | -$25.3K | 0.19% | 95 |
|
|
2024
Q4 | $358K | Sell |
4,167
-193
| -4% | -$16.6K | 0.25% | 75 |
|
|
2024
Q3 | $519K | Buy |
+4,360
| New | +$519K | 0.35% | 69 |
|
|
2024
Q2 | – | Sell |
-4,837
| Closed | -$621K | – | 65 |
|
|
2024
Q1 | $621K | Buy |
4,837
+27
| +0.6% | +$3.47K | 0.43% | 67 |
|
|
2023
Q4 | $499K | Sell |
4,810
-78
| -2% | -$8.09K | 0.38% | 71 |
|
|
2023
Q3 | $445K | Hold |
4,888
| – | – | 0.37% | 71 |
|
|
2023
Q2 | $396K | Sell |
4,888
-190
| -4% | -$15.4K | 0.26% | 102 |
|
|
2023
Q1 | $404K | Buy |
5,078
+38
| +0.8% | +$3.02K | 0.29% | 97 |
|
|
2022
Q4 | $341K | Sell |
5,040
-660
| -12% | -$44.7K | 0.25% | 101 |
|
|
2022
Q3 | $284K | Hold |
5,700
| – | – | 0.22% | 101 |
|
|
2022
Q2 | $318K | Sell |
5,700
-200
| -3% | -$11.2K | 0.23% | 86 |
|
|
2022
Q1 | $328K | Hold |
5,900
| – | – | 0.2% | 91 |
|
|
2021
Q4 | $330K | Buy |
+5,900
| New | +$330K | 0.21% | 92 |
|